Welcome to our dedicated page for Alexandria Real Estate Eq news (Ticker: ARE), a resource for investors and traders seeking the latest updates and insights on Alexandria Real Estate Eq stock.
Alexandria Real Estate Equities Inc (NYSE: ARE) operates at the intersection of cutting-edge science and premium urban real estate, developing collaborative campuses for leading life science and technology tenants. This page provides investors and industry professionals with direct access to the company's official announcements and market-moving developments.
Track ARE's latest press releases, including earnings reports, strategic acquisitions, and campus expansions in key innovation hubs like Boston and San Francisco. Discover updates on lease agreements with biopharma leaders, sustainability initiatives, and Labspace® infrastructure advancements shaping modern R&D ecosystems.
Our curated news feed delivers timely, accurate information to support informed analysis of ARE's position in the life science REIT sector. Content is rigorously verified to meet financial reporting standards, offering clarity on how urban innovation clusters drive long-term value creation.
Bookmark this page for streamlined access to Alexandria Real Estate Equities' corporate communications, or check back regularly to monitor emerging trends in technology-driven commercial property development.
Alexandria Real Estate Equities (NYSE: ARE) announced the tax treatment for its 2021 distributions, detailing the composition of dividends, capital gains, and return of capital. The report urges stockholders to consult tax advisors regarding their specific tax implications. The distributions per share include $4.420000 total with various components classified under ordinary dividends, capital gains, and return of capital, highlighting a significant portion classified as qualified dividends. The record and payment dates for distributions are also specified.
On January 18, 2022, Alexandria Real Estate Equities (NYSE: ARE) announced the full exercise of an underwriter's option to purchase an additional 1,050,000 shares at $210.00 each, increasing its public offering to 8,050,000 shares. The proceeds from future settlements of the forward sale agreements will fund acquisitions and construction projects. The offering will allow Alexandria to delay the issuance of shares while managing capital needs. No immediate proceeds will be received from this sale.
On January 10, 2022, Alexandria Venture Investments announced its recognition as the top corporate investor in biopharma for new deal volume for the fifth consecutive year, according to Silicon Valley Bank's 2022 report. This accolade underscores Alexandria's commitment to enhancing human health through significant investments in the life sciences sector. The company has generated over 10x returns for various portfolio companies since its inception in 1996. Alexandria's market capitalization stands at $38.6 billion, with large investments in urban life science and technology campuses, reflecting its strategic focus on key innovation areas.
On January 7, 2022, Alexandria Real Estate Equities (NYSE: ARE) announced the closing of a public offering of 7,000,000 shares at $210.00 per share. The offering involved forward sale agreements with major banks including JPMorgan and Bank of America. While the company will not receive initial proceeds from the shares sold by forward purchasers, future proceeds will be allocated towards acquisitions, development projects, and general corporate purposes. Alexandria, recognized for its focus on collaborative life science and technology campuses, continues to establish a significant market presence in key U.S. locations.
On January 4, 2022, Alexandria Real Estate Equities, Inc. (NYSE: ARE) announced its upsized public offering of 7,000,000 shares of common stock priced at $210.00 per share. The offering includes a 30-day option for underwriters to purchase an additional 1,050,000 shares. The offering's expected closing date is on or about January 7, 2022. The proceeds, if any, from future settlements of forward sale agreements are planned to fund acquisitions and development projects, as well as general corporate purposes.
Alexandria Real Estate Equities (NYSE: ARE) announced a public offering of 6,500,000 shares of its common stock, with a potential 30-day option for underwriters to buy an additional 975,000 shares. The financing aims to support pending acquisitions and fund development projects. The company will not initially receive proceeds from the sale, as the forward purchasers will first sell these shares to underwriters. Settlement of the forward sale agreements is expected by September 15, 2023.
On December 14, 2021, Alexandria Real Estate Equities (NYSE: ARE) announced a partnership with Camp Kita, a nonprofit organization supporting children affected by suicide. Through a significant donation, Alexandria will provide 28 acres in Acton, Maine, for a new camp facility expected to open in summer 2023. The camp aims to serve as a nurturing space for young survivors, offering resources for grief management and community connection. Alexandria's broader social responsibility efforts include addressing various societal challenges, emphasizing their commitment to enhancing human health and quality of life.
Alexandria Real Estate Equities (NYSE: ARE) declared a quarterly cash dividend of $1.15 per common share for Q4 2021, payable on January 14, 2022. This brings the total dividend for 2021 to $4.48 per share, a 6% increase from 2020. The dividend reflects the company's strong net cash from operating activities while maintaining a low 58% funds from operations payout ratio, allowing for reinvestment in development projects. Alexandria is dedicated to growth in life sciences and technology sectors.
Alexandria Real Estate Equities, Inc. (NYSE: ARE) will host a conference call and audio webcast on February 1, 2022, at 3:00 p.m. ET to discuss its fourth quarter and year-end 2021 operating and financial results. The results will be released after the market closes on January 31, 2022. Interested participants can join the call by dialing (833) 366-1125 (U.S.) or (412) 902-6738, or listen via the company’s website. A replay will be available from 5:00 p.m. ET on February 1 until February 8, 2022.
 
             
      